MEROPENEM-VABORBACTAM

MEROPENEM-VABORBACTAM was reported 50 times

These side effects are most commonly reported by patients taking MEROPENEM-VABORBACTAM:

# Side effect Count
0 OFF LABEL USE 19
1 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7
2 DEATH 5
3 CONDITION AGGRAVATED 3
4 DRUG INEFFECTIVE 3
5 ERYTHEMA 3
6 HYPERSENSITIVITY 3
7 PERIPHERAL SWELLING 3
8 RASH 3
9 ACUTE KIDNEY INJURY 2
10 BLOOD CULTURE POSITIVE 2
11 CREATININE RENAL CLEARANCE INCREASED 2
12 DRUG ERUPTION 2
13 DRUG RESISTANCE 2
14 HEADACHE 2
15 INFLAMMATION 2
16 INJECTION SITE PAIN 2
17 MINIMUM INHIBITORY CONCENTRATION INCREASED 2
18 PAIN IN EXTREMITY 2
19 PRODUCT CONTAINER ISSUE 2
20 PRURITUS 2
21 RASH PRURITIC 2
22 SEIZURE 2
23 STEVENS-JOHNSON SYNDROME 2
24 SWELLING 2
25 TOXIC EPIDERMAL NECROLYSIS 2
26 ABDOMINAL ABSCESS 1
27 ABDOMINAL WALL ABSCESS 1
28 ALANINE AMINOTRANSFERASE INCREASED 1
29 ALLERGIC COUGH 1
30 ASPARTATE AMINOTRANSFERASE INCREASED 1
31 ASTHENIA 1
32 BACTERIAL DISEASE CARRIER 1
33 BLOOD CREATININE INCREASED 1
34 BRAIN ABSCESS 1
35 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1
36 BURNING SENSATION 1
37 CONFUSIONAL STATE 1
38 DEVICE RELATED INFECTION 1
39 DIARRHOEA 1
40 DISEASE PROGRESSION 1
41 DRUG DIVERSION 1
42 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
43 EPISTAXIS 1
44 EXPIRED PRODUCT ADMINISTERED 1
45 EXTRAVASATION 1
46 FLANK PAIN 1
47 HALLUCINATION, VISUAL 1
48 HEPATOTOXICITY 1
49 HYPOAESTHESIA 1
50 HYPOTENSION 1
51 HYPOXIA 1
52 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1
53 INFUSION SITE ERYTHEMA 1
54 INFUSION SITE EXTRAVASATION 1
55 INFUSION SITE PHLEBITIS 1
56 INFUSION SITE SWELLING 1
57 INJECTION SITE IRRITATION 1
58 INTESTINAL ISCHAEMIA 1
59 LIVER FUNCTION TEST INCREASED 1
60 MEDICAL DEVICE PAIN 1
61 MOBILITY DECREASED 1
62 MYOCARDIAL INFARCTION 1
63 NEUROLOGICAL EXAMINATION ABNORMAL 1
64 PANCREATIC ABSCESS 1
65 PARAESTHESIA 1
66 PNEUMONIA 1
67 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 1
68 PRODUCT LABEL CONFUSION 1
69 PRODUCT PREPARATION ERROR 1
70 PRODUCT USE IN UNAPPROVED INDICATION 1
71 PYREXIA 1
72 RASH ERYTHEMATOUS 1
73 RESPIRATORY FAILURE 1
74 TREATMENT FAILURE 1
75 URINARY TRACT INFECTION 1
76 VASCULAR ACCESS SITE COMPLICATION 1
77 WHITE BLOOD CELL COUNT DECREASED 1
78 WHITE BLOOD CELL COUNT INCREASED 1